LOSS PER SHARE (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2024

Dec. 31, 2023

Earnings Per Share [Abstract]

SCHEDULE OF EARNINGS PER SHARE ANTI DILUTIVE

	September 30, 2024		September 30, 2023
Series A Preferred Stock		139,790,000		-
Series C Preferred Stock (1)		-		63,090,000
Convertible Notes		-		17,680
Warrants		71,064,035		108,734
Total common stock equivalents		210,854,035		63,216,414

(1) On January 10, 2024, the Company redomiciled and exchanged all outstanding shares of its pre-existing Series C Preferred Stock for shares of a new class of Series A Preferred Stock (Note 1 – Organization and Nature of Operations). The Statement of Changes in Stockholders’ Equity (Deficit)/Member’s Equity for the three and nine months ended September 30, 2024 has been retrospectively restated to reflect this change.

	Year Ended		Year Ended
	December 31,		December 31,
	2023		2022
Series C preferred stock		63,090,000		-
Warrants		2,608,734		-
Total common stock equivalents		65,698,734		-